Prevalence of Hypertensive Phenotypes after Preeclampsia:A Prospective Cohort Study

Hypertension

Volumn 71, Issue 1, 2018, Pages 103-109

  Ditisheim, Agnès ^a,c   Wuerzner, Grégoire ^d   Ponte, Belen ^a,b   Vial, Yvan ^e,f   Irion, Olivier ^a,c   Burnier, Michel ^d   Boulvain, Michel ^a,c   Pechère Bertschi, Antoinette ^a,d  

^a From the Hypertension Centre   (United States)

^b Department of Medicine   (United States)

^c and Service of Obstetrics ^*  (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e Service of Nephrology and Hypertension   (United States)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

blood pressure; masked hypertension; postpartum period; preeclampsia; pregnancy

Indexed keywords

LABETALOL; NIFEDIPINE; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MASKED HYPERTENSION; PHENOTYPE; PREECLAMPSIA; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; WHITE COAT HYPERTENSION; CLASSIFICATION; GENETICS; PHYSIOLOGY; PREGNANCY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; SWITZERLAND;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; PHENOTYPE; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SWITZERLAND;

EID: 85038359801     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.117.09799     Document Type: Article

References (44)

1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1-7. doi: 10. 1016/j. ejogrb. 2013. 05. 005.
2. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156:918-930. doi: 10. 1016/j. ahj. 2008. 06. 042.
3. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323-e333. doi: 10. 1016/S2214-109X(14)70227-X.
4. Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122-1131. doi: 10. 1097/01. AOG. 0000437382. 03963. 88.
5. National Institute for Health and Clinical Excellence: Guidance. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: RCOG Press; 2010.
6. Lowe SA, Bowyer L, Lust K, McMahon LP, Morton M, North RA, Paech M, Said JM. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55:e1-e29.
7. Mounier-Vehier C, Amar J, Boivin JM, Denolle T, Fauvel JP, Plu-Bureau G, Tsatsaris V, Blacher J. Hypertension artérielle et grossesse. Consensus d'experts de la Société française d'hypertension artérielle, filiale de la Société française de cardiologie. Presse Med. 2016;45:682-699. doi: 10. 1016/j. lpm. 2016. 05. 012.
8. Halligan A, Shennan A, Lambert PC, de Swiet M, Taylor DJ. Diurnal blood pressure difference in the assessment of preeclampsia. Obstet Gynecol. 1996;87:205-208. doi: 10. 1016/0029-7844(95)00379-7.
9. Benedetto C, Zonca M, Marozio L, Dolci C, Carandente F, Massobrio M. Blood pressure patterns in normal pregnancy and in pregnancy-induced hypertension, preeclampsia, and chronic hypertension. Obstet Gynecol. 1996;88(4 pt 1):503-510.
10. Brown MA, Davis GK, McHugh L. The prevalence and clinical significance of nocturnal hypertension in pregnancy. J Hypertens. 2001;19:1437-1444.
11. Higashi Y, Oshima T, Ozono R, Nakano Y, Matsuura H, Kambe M, Kajiyama G. Nocturnal decline in blood pressure is attenuated by NaCl loading8 in salt-sensitive patients with essential hypertension: noninvasive 24-hour ambulatory blood pressure monitoring. Hypertension. 1997;30(2 pt 1):163-167.
12. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
13. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;2:97-104. doi: 10. 1016/j. preghy. 2014. 02. 001.
14. Mancia G, Fagard R, Narkiewicz K, et al. Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159-2219. doi: 10. 1093/eurheartj/eht151.
15. O'Brien E, Parati G, Stergiou G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731-1768. doi: 10. 1097/HJH. 0b013e328363e964.
16. Castiglioni P, Parati G, Brambilla L, Brambilla V, Gualerzi M, Di Rienzo M, Coruzzi P. Detecting sodium-sensitivity in hypertensive patients: information from 24-hour ambulatory blood pressure monitoring. Hypertension. 2011;57:180-185. doi: 10. 1161/ HYPERTENSIONAHA. 110. 158972.
17. Martillotti G, Ditisheim A, Burnier M, Wagner G, Boulvain M, Irion O, Pechère-Bertschi A. Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia. Hypertension. 2013;62:802-808. doi: 10. 1161/HYPERTENSIONAHA. 113. 01916.
18. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:938-948. doi: 10. 1016/S0140-6736(10)60309-1.
19. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974. doi: 10. 1136/ bmj. 39335. 385301. BE.
20. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243-1262. doi: 10. 1161/CIR. 0b013e31820faaf8.
21. National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 [Internet]. London: Royal College of Physicians (UK); 2011 Aug. https://www. ncbi. nlm. nih. gov/books/NBK83274/.
22. Magee L, von Dadelszen P. Prevention and treatment of postpartum hypertension. Datab Syst Rev. 2013:4:CD004351.
23. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24:52-58. doi: 10. 1038/ajh. 2010. 203.
24. Mancia G, Bombelli M, Brambilla G, Facchetti R, Sega R, Toso E, Grassi G. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension. 2013;62:168-174. doi: 10. 1161/ HYPERTENSIONAHA. 111. 00690.
25. Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens. 2016;34:593-599. doi: 10. 1097/HJH. 0000000000000832.
26. Bar J, Maymon R, Padoa A, Wittenberg C, Boner G, Ben-Rafael Z, Hod M. White coat hypertension and pregnancy outcome. J Hum Hypertens. 1999;13:541-545.
27. Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension during pregnancy. BJOG. 2005;112:601-606. doi: 10. 1111/j. 1471-0528. 2004. 00516. x.
28. Angeli F, Reboldi G, Verdecchia P. Masked hypertension: evaluation, prognosis, and treatment. Am J Hypertens. 2010;23:941-948. doi: 10. 1038/ajh. 2010. 112.
29. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, Hatzitolios A, Rizos Z, Sion M, Zakopoulos N. Target organ damage in "white coat hypertension" and "masked hypertension". Am J Hypertens. 2008;21:393-399. doi: 10. 1038/ajh. 2008. 15.
30. Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens. 2008;26:1715-1725. doi: 10. 1097/HJH. 0b013e3282fbcedf.
31. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-426.
32. Ishikawa J, Hoshide S, Eguchi K, Schwartz JE, Pickering TG, Shimada K, Kario K. Masked hypertension defined by ambulatory blood pressure monitoring is associated with an increased serum glucose level and urinary albumin-creatinine ratio. J Clin Hypertens (Greenwich). 2010;12:578-587. doi: 10. 1111/j. 1751-7176. 2010. 00286. x.
33. Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S, Yoshihara F, Nakahama H, Inenaga T, Kawano Y. Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens. 2006;19:880-886. doi: 10. 1016/j. amjhyper. 2006. 03. 006.
34. Mallion JM, Clerson P, Bobrie G, Genes N, Vaisse B, Chatellier G. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens. 2006;24:2365-2370. doi: 10. 1097/01. hjh. 0000251895. 55249. 82.
35. Felder RA, White MJ, Williams SM, Jose PA. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens. 2013;22:65-76. doi: 10. 1097/MNH. 0b013e32835b3693.
36. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37(2 pt 2):429-432.
37. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350:1734-1737. doi: 10. 1016/S0140-6736(97)05189-1.
38. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis. 1999;33:29-35.
39. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10:143-155. doi: 10. 1038/nrcardio. 2013. 1.
40. Bryant AS, Seely EW, Cohen A, Lieberman E. Patterns of pregnancyrelated hypertension in black and white women. Hypertens Pregnancy. 2005;24:281-290. doi: 10. 1080/10641950500281134.
41. Wolf M, Shah A, Jimenez-Kimble R, Sauk J, Ecker JL, Thadhani R. Differential risk of hypertensive disorders of pregnancy among Hispanic women. J Am Soc Nephrol. 2004;15:1330-1338.
42. Redman CW. Hypertension in pregnancy: the NICE guidelines. Heart. 2011;97:1967-1969. doi: 10. 1136/heartjnl-2011-300949.
43. Levine LD, Nkonde-Price C, Limaye M, Srinivas SK. Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia. J Perinatol. 2016;36:1079-1082. doi: 10. 1038/jp. 2016. 137.
44. Visser VS, Hermes W, Franx A, Koopmans CM, van Pampus MG, Mol BW, de Groot CJ. High blood pressure six weeks postpartum after hypertensive pregnancy disorders at term is associated with chronic hypertension. Pregnancy Hypertens. 2013;3:242-247. doi: 10. 1016/j. preghy. 2013. 07. 002.